15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A systematic review on the use of topical hemostats in trauma and emergency surgery

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          A wide variety of hemostats are available as adjunctive measures to improve hemostasis during surgical procedures if residual bleeding persists despite correct application of conventional methods for hemorrhage control. Some are considered active agents, since they contain fibrinogen and thrombin and actively participate at the end of the coagulation cascade to form a fibrin clot, whereas others to be effective require an intact coagulation system. The aim of this study is to provide an evidence-based approach to correctly select the available agents to help physicians to use the most appropriate hemostat according to the clinical setting, surgical problem and patient’s coagulation status.

          Methods

          The literature from 2000 to 2016 was systematically screened according to PRISMA [Preferred Reporting Items for Systematic Reviews and Meta-Analyses] protocol. Sixty-six articles were reviewed by a panel of experts to assign grade of recommendation (GoR) and level of evidence (LoE) using the GRADE [Grading of Recommendations Assessment, Development and Evaluation] system, and a national meeting was held.

          Results

          Fibrin adhesives, in liquid form (fibrin glues) or with stiff collagen fleece (fibrin patch) are effective in the presence of spontaneous or drug-induced coagulation disorders. Mechanical hemostats should be preferred in patients who have an intact coagulation system. Sealants are effective, irrespective of patient’s coagulation status, to improve control of residual oozing. Hemostatic dressings represent a valuable option in case of external hemorrhage at junctional sites or when tourniquets are impractical or ineffective.

          Conclusions

          Local hemostatic agents are dissimilar products with different indications. A knowledge of the properties of each single agent should be in the armamentarium of acute care surgeons in order to select the appropriate product in different clinical conditions.

          Related collections

          Most cited references62

          • Record: found
          • Abstract: found
          • Article: not found

          Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force.

          While grading the strength of recommendations and the quality of underlying evidence enhances the usefulness of clinical guidelines, the profusion of guideline grading systems undermines the value of the grading exercise. An American College of Chest Physicians (ACCP) task force formulated the criteria for a grading system to be utilized in all ACCP guidelines that included simplicity and transparency, explicitness of methodology, and consistency with current methodological approaches to the grading process. The working group examined currently available systems, and ultimately modified an approach formulated by the international GRADE group. The grading scheme classifies recommendations as strong (grade 1) or weak (grade 2), according to the balance among benefits, risks, burdens, and possibly cost, and the degree of confidence in estimates of benefits, risks, and burdens. The system classifies quality of evidence as high (grade A), moderate (grade B), or low (grade C) according to factors that include the study design, the consistency of the results, and the directness of the evidence. For all future ACCP guidelines, The College has adopted a simple, transparent approach to grading recommendations that is consistent with current developments in the field. The trend toward uniformity of approaches to grading will enhance the usefulness of practice guidelines for clinicians.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A special report on the chitosan-based hemostatic dressing: experience in current combat operations.

            Hemorrhage remains a leading cause of death in both civilian and military trauma patients. The HemCon chitosan-based hemostatic dressing is approved by the US Food and Drug Administration (FDA) for hemorrhage control. Animal data have shown the HemCon dressing to reduce hemorrhage and improve survival. The purpose of this article is to report preliminary results of the hemostatic efficacy of the HemCon dressing used in the prehospital setting on combat casualties. A request for case information on use of HemCon dressings in Operation Iraqi Freedom and Operation Enduring Freedom was sent to deployed Special Forces combat medics, physicians, and physician assistants. Sixty-eight uses of the HemCon dressing were reported and reviewed by two US Army physicians. Four of the 68 cases were determined duplicative resulting in a total of 64 combat uses. Dressings were utilized externally on the chest, groin, buttock, and abdomen in 25 cases; on extremities in 35 cases; and on neck or facial wounds in 4 cases. In 66% of cases, dressings were utilized following gauze failure and were 100% successful. In 62 (97%) of the cases, the use of the HemCon dressing resulted in cessation of bleeding or improvement in hemostasis. There were two reported dressing failures that occurred with blind application of bandages up into large cavitational injuries. Dressings were reported to be most useful on areas where tourniquets could not be applied to control bleeding. The dressings were reported to be most difficult to use in extremity injuries where they could not be placed easily onto or into the wounds. No complications or adverse events were reported. This report on the field use of the HemCon dressing by medics suggests that it is a useful hemostatic dressing for prehospital combat casualties and supports further study to confirm efficacy.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Fibrin Sealant: The Only Approved Hemostat, Sealant, and Adhesive—a Laboratory and Clinical Perspective

              Background. Fibrin sealant became the first modern era material approved as a hemostat in the United States in 1998. It is the only agent presently approved as a hemostat, sealant, and adhesive by the Food and Drug Administration (FDA). The product is now supplied as patches in addition to the original liquid formulations. Both laboratory and clinical uses of fibrin sealant continue to grow. The new literature on this material also continues to proliferate rapidly (approximately 200 papers/year). Methods. An overview of current fibrin sealant products and their approved uses and a comprehensive PubMed based review of the recent literature (February 2012, through March 2013) on the laboratory and clinical use of fibrin sealant are provided. Product information is organized into sections based on a classification system for commercially available materials. Publications are presented in sections based on both laboratory research and clinical topics are listed in order of decreasing frequency. Results. Fibrin sealant remains useful hemostat, sealant, and adhesive. New formulations and applications continue to be developed. Conclusions. This agent remains clinically important with the recent introduction of new commercially available products. Fibrin sealant has multiple new uses that should result in further improvements in patient care.
                Bookmark

                Author and article information

                Contributors
                +39 02 6444 5381 , ochiara@yahoo.com
                stefania.cimbanassi@ospedaleniguarda.it
                giovanni.bellanova@asl.taranto.it
                massimo.chiarugi@med.unipi.it
                andrea.mingoli@uniroma1.it
                giorgio.olivero@unito.it
                sergio.ribaldi@uniroma1.it
                gregorio.tugnoli@ausl.bologna.it
                silvia.basilico85@gmail.com
                francesca.bindi@ospedaleniguarda.it
                laura.briani@ospedaleniguarda.it
                federica.renzi@ospedaleniguarda.it
                piero.chirletti@uniroma1.it
                giuseppe.digrezia@gmail.com
                antonio.wolf@virgilio.it
                rinaldo.marzaioli@uniba.it
                giuseppenoschese@gmail.com
                nazario.portolani@unibs.it
                paoloruscelli@ospedaliriuniti.marche.it
                maurozago.md@gmail.com
                sgardello@outlook.com
                franco.stagnitti@uniroma1.it
                stefanominiello@yahoo.it
                Journal
                BMC Surg
                BMC Surg
                BMC Surgery
                BioMed Central (London )
                1471-2482
                29 August 2018
                29 August 2018
                2018
                : 18
                : 68
                Affiliations
                [1 ]ISNI 0000 0004 1757 2822, GRID grid.4708.b, General Surgery-Trauma Team, , State University of Milano, Niguarda Hospital Milano, ; Piazza Benefattori dell’Ospedale, 3, 20162 Milan, Italy
                [2 ]GRID grid.416200.1, General Surgery-Trauma Team, , Niguarda Hospital, ; Milan, Italy
                [3 ]General Surgery, SS Annunziata Hospital, Taranto, Italy
                [4 ]GRID grid.414498.4, Emergency Surgery Unit, , State University of Pisa, Cisanello Hospital, ; Pisa, Italy
                [5 ]GRID grid.417007.5, Trauma Surgery Unit-Department of Surgery-Emergency Surgery Department Policlinico Umberto I-Rome, ; Rome, Italy
                [6 ]ISNI 0000 0001 2336 6580, GRID grid.7605.4, Department of Surgical Sciences, , State University of Torino, ; Turin, Italy
                [7 ]GRID grid.417007.5, Emergency Surgery, , Umberto I Hospital, ; Rome, Italy
                [8 ]ISNI 0000 0004 1759 7093, GRID grid.416290.8, Trauma Surgery, , Maggiore Hospital, ; Bologna, Italy
                [9 ]GRID grid.7841.a, General Surgery and Pancreatic Surgery Unit, , State University La Sapienza, ; Rome, Italy
                [10 ]Emergency Surgery, Ladolfi Hospital, Avellino, Italy
                [11 ]GRID grid.413172.2, Honorable Chief- Emergency Surgery, , Cardarelli Hospital, ; Naples, Italy
                [12 ]ISNI 0000 0001 0120 3326, GRID grid.7644.1, Department of Emergency and Transplant Surgery, , State University of Bari, ; Bari, Italy
                [13 ]GRID grid.413172.2, Trauma Center, , A.O.R.N Cardarelli, ; Naples, Italy
                [14 ]Department of Clinical and Experimental Sciences-State University of Brescia, Bari, Italy
                [15 ]GRID grid.415845.9, Department of Emergency Surgery, Ospedali Riuniti, ; Ancona, Italy
                [16 ]Minimally Invasive Surgery Unit- Policlinico S. Pietro, Ponte San Pietro, Bergamo, Italy
                [17 ]State University of Rome “La Sapienza”-Polo Pontino, Latina, Italy
                [18 ]ISNI 0000 0001 0120 3326, GRID grid.7644.1, Department of Surgery, , University of Bari, ; Bari, Italy
                Article
                398
                10.1186/s12893-018-0398-z
                6116382
                30157821
                bd8044b4-b817-4c77-96ff-ded6cf19f7c4
                © The Author(s). 2018

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 13 March 2018
                : 20 August 2018
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2018

                Surgery
                hemorrhage,trauma,emergency surgery,hemostats,fibrin adhesives,sealants,mechanical hemostats,hemostatic dressings,systematic review

                Comments

                Comment on this article